Evaluation of the Effectiveness as to the Provision of Biological Safety of Works with Fixed Rabies Virus in the Process of Anti-Rabies Immunoglobulin Manufacturing
https://doi.org/10.21055/0370-1069-2012-4-29-32
Abstract
Analyzed is the performance of works with the strains of fixed rabies virus under the conditions of anti-rabies immunoglobulin manufacturing. Evaluated is the effectiveness of the established system for the provision of biological safety, which has allowed for safe manufacturing of anti-rabies immunoglobulin within the period of 12 years.
About the Authors
A. K. Nikiforov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
E. G. Abramova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
S. A. Eremin
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
M. N. Lyapin
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
References
1. Nikiforov A.K., Dyatlov I.A., Yeremin S.A., Volokh O.A., Lyapin M.N. [Qualification of the risks as the basis for assuring biologically safe handling of the rabies virus production strains]. Probl. Osobo Opasn. Infek. 2006; (92):38–40.
2. Selimov M.A., Morogova V.M. [Phenol lyophilized vaccines obtained from the brain tissue of sheep]. In: [Methods of laboratory investigations on rabies virus]. Geneva: WHO; 1975. P. 201–3.
3. Selimov M.A. [Rabies]. M.: Meditsina; 1978. 336 p.
4. Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5th edition. U.S. Department of Health and Human Services; Public Health Service; Centers for Disease Control and Prevention; National Institutes of Health; 2007. 360 p.
5. Fundamentals of biosafety in laboratories. 3rd edition. Department of Foreign Affairs and International Trade (Canada); 2004. 108 p.
6. Нarding A.L., Byers K.B. Epidemiology of Laboratory-Associated Infection. In: Fleming D.O., Hunt D.L. Biological Safety: principles and practices. 3rd ed. Washington DC: ASM Press; 2000. P. 35–54.
7. Laboratory biosafety manual. 3rd edition. Geneva: WHO; 2004. 190 p.
8. Meslin F.-X., Kaplan V.V., Кoprowsky H., editors. Laboratory techniques in rabies. Geneva: WHO; 1996. 469 p.
9. Pike R.M., Sulkin S.E., Schulze M.L. Continuing importance of laboratory-acquired infections. Am. J. Pub. Hlth. 1965; 55:190–9.
10. Рike R.M. Laboratory-associated infections: summary and analysis of 3921 cases. Health. Lab. Sci. 1976; 13:105–14.
11. Pike R.M. Past and present hazards of working with infectious agents. Arch. Pathol. Lab. Med. 1978; 102:333–6.
12. Pike R.M. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu. Rev. Microbiol. 1979; 33: 41–66.
13. Richardson J.H., Barkley W.E., editors. Biosafety in microbiological and biomedical laboratories. 1st ed. Washington, DC; 1984.
14. Sulkin S.E., Pike R.M. Survey of laboratory-acquired infections. Am. J. Pub. Hlth. 1951; 41:769–81.
Review
For citations:
Nikiforov A.K., Abramova E.G., Eremin S.A., Lyapin M.N. Evaluation of the Effectiveness as to the Provision of Biological Safety of Works with Fixed Rabies Virus in the Process of Anti-Rabies Immunoglobulin Manufacturing. Problems of Particularly Dangerous Infections. 2012;(4(114)):29-32. (In Russ.) https://doi.org/10.21055/0370-1069-2012-4-29-32
Views:
573
Email this article 